Wu DC, Goldman MP
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery
2018-02-05
http://europepmc.org/abstract/med/29406482
Calcium hydroxylapatite (CaHA) is currently the only FDA-approved soft-tissue filler indicated for augmentation of the dorsal hand. Although the treatment is generally safe and effective, adverse side effects such as swelling and edema postinjection are common and can sometimes be debilitating.In this study, the authors explore the utility of triamcinolone acetate coinjection with CaHA to the dorsal hands to mitigate adverse effects and improve patient experience.